Cargando…

Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection — New York, 2022

Detalles Bibliográficos
Autores principales:	Rosenberg, Eli S., Dorabawila, Vajeera, Hart-Malloy, Rachel, Anderson, Bridget J., Miranda, Wilson, O’Donnell, Travis, Gonzalez, Charles J., Abrego, Meaghan, DelBarba, Charlotte, Tice, Cori J., McGarry, Claire, Mitchell, Ethan C., Boulais, Michele, Backenson, Bryon, Kharfen, Michael, McDonald, James, Bauer, Ursula E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205166/ https://www.ncbi.nlm.nih.gov/pubmed/37339074 http://dx.doi.org/10.15585/mmwr.mm7220a4

Ejemplares similares

New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
por: Rosenberg, Eli S., et al.
Publicado: (2021)

New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021
por: Rosenberg, Eli S., et al.
Publicado: (2021)

An Integrated Mosquito Surveillance Module in New York State
por: Chang, Hwa-Gan, et al.
Publicado: (2017)

Comparison of COVID-19 home-testers vs. laboratory-testers in New York State (excluding New York City), November 2021 to April 2022
por: Dorabawila, Vajeera, et al.
Publicado: (2023)

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022
por: Farrar, Jennifer L., et al.
Publicado: (2022)

Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022
por: Duffy, Jonathan, et al.
Publicado: (2022)

JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox — United States, May 22, 2022–January 31, 2023
por: Owens, Lauren E., et al.
Publicado: (2023)

Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine — California, May 2022–May 2023
por: Schildhauer, Samuel, et al.
Publicado: (2023)

Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study — United States, August 19, 2022–March 31, 2023
por: Dalton, Alexandra F., et al.
Publicado: (2023)

1778. Same Story, Different Outbreak: Lessons from a Survey Study Investigating JYNNEOS Mpox Public Vaccination Clinic Establishment in New Hampshire
por: Kang, HeeEun, et al.
Publicado: (2023)

COVID-19 Vaccination and Hospitalization Among Persons Living With Diagnosed HIV in New York State
por: Rosenthal, Elizabeth M., et al.
Publicado: (2023)

COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021
por: León, Tomás M., et al.
Publicado: (2022)

Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
por: Payne, Amanda B., et al.
Publicado: (2022)

Covid-19 Vaccine Effectiveness in New York State
por: Rosenberg, Eli S., et al.
Publicado: (2021)

Contact tracing: Characteristics of COVID-19 cases that provided contacts
por: Dorabawila, Vajeera, et al.
Publicado: (2023)

Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022
por: Kriss, Jennifer L., et al.
Publicado: (2022)

JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional study
por: Lee, Jaeeun, et al.
Publicado: (2023)

FDA's authorized “JYNNEOS” vaccine for counteracting monkeypox global public health emergency; an update – Correspondence
por: Sah, Ranjit, et al.
Publicado: (2022)

1495. Mpox Vaccine Immunity in People Living with HIV (PLWH) During The 2022 Mpox Outbreak in New York City
por: Kottkamp, Angelica C, et al.
Publicado: (2023)

Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo
por: Priyamvada, Lalita, et al.
Publicado: (2022)

Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications and Adverse Effects of JYNNEOS and ACAM2000 Monkeypox Vaccines
por: Meo, Sultan Ayoub, et al.
Publicado: (2022)

Exposure to Lymphocytic Choriomeningitis Virus, New York, USA
por: Knust, Barbara, et al.
Publicado: (2011)

Dead Crow Density and West Nile Virus Monitoring, New York
por: Eidson, Millicent, et al.
Publicado: (2005)

Babesia microti, Upstate New York
por: Kogut, Sarah J., et al.
Publicado: (2005)

Mpox-associated myopericarditis
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2023)

Characteristics of JYNNEOS Vaccine Recipients Before and During a Large Multiday LGBTQIA+ Festival — Louisiana, August 9–September 5, 2022
por: Soelaeman, Rieza H., et al.
Publicado: (2022)

Mpox respiratory transmission: the state of the evidence
por: Beeson, Amy, et al.
Publicado: (2023)

2666. Rates of STI Testing and Diagnoses among Patients with Mpox in New York City, 2022
por: Gunaratne, Shauna, et al.
Publicado: (2023)

Molecular Epidemiology of Eastern Equine Encephalitis Virus, New York
por: Young, David S., et al.
Publicado: (2008)

Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA
por: Lash, Maura K., et al.
Publicado: (2023)

A Health Equity Approach for Implementation of JYNNEOS Vaccination at Large, Community-Based LGBTQIA+ Events — Georgia, August 27–September 5, 2022
por: Millman, Alexander J., et al.
Publicado: (2022)

Mpox: Risks and approaches to prevention
por: Amer, Fatma, et al.
Publicado: (2023)

Viroporins of Mpox Virus
por: Basu, Kingshuk, et al.
Publicado: (2023)

Demographics and disease associations of patients with mpox and recipients of mpox vaccine from safety net hospitals in New York City: A cross-sectional study
por: Cline, Abigail, et al.
Publicado: (2023)

Notes from the Field: Fatal Yellow Fever in a Traveler Returning From Peru — New York, 2016
por: Newman, Alexandra P., et al.
Publicado: (2017)

1022. Detection of Mpox virus with the Cepheid Xpert Mpox assay in oropharyngeal, anorectal and cutaneous lesion swab specimens
por: Damhorst, Gregory, et al.
Publicado: (2023)

2674. Disparities in Mpox Care: Use of the Social Vulnerability Index to Predict Mpox Infections
por: Leonard, Michael, et al.
Publicado: (2023)

Recent advances on human mpox
por: Orassay, Aliya, et al.
Publicado: (2022)

The Global Impact of Mpox on LGBTQIA+
por: Corpuz, Jeff Clyde G.
Publicado: (2023)

Auricular manifestation of Mpox (monkeypox)
por: Williams, George, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c3squgcu52r4ic44htpjjlb2ji